Your browser doesn't support javascript.
COVID-19 prevention and multiple sclerosis management: The SAFE pathway for the post-peak.
Buonomo, Antonio; Brescia Morra, Vincenzo; Zappulo, Emanuela; Lanzillo, Roberta; Gentile, Ivan; Montella, Emma; Triassi, Maria; Palladino, Raffaele; Moccia, Marcello.
  • Buonomo A; Section of Infectious Diseases, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
  • Brescia Morra V; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Italy.
  • Zappulo E; Section of Infectious Diseases, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy.
  • Lanzillo R; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Italy.
  • Gentile I; Section of Infectious Diseases, Department of Clinical Medicine and Surgery, Federico II University of Naples, Italy; UNESCO Chair on Health Education and Sustainable Development, Federico II University of Naples, Italy.
  • Montella E; Department of Hygiene, Preventive and Industrial Medicine, Federico II University Hospital, Naples, Italy.
  • Triassi M; Department of Public Health, Federico II University of Naples, Italy.
  • Palladino R; Department of Public Health, Federico II University of Naples, Italy; Department of Primary Care and Public Health, Imperial College London, United Kingdom.
  • Moccia M; Multiple Sclerosis Clinical Care and Research Centre, Department of Neuroscience, Reproductive Science and Odontostomatology, Federico II University of Naples, Italy.
Mult Scler Relat Disord ; 44: 102282, 2020 Sep.
Article in English | MEDLINE | ID: covidwho-592342
ABSTRACT

BACKGROUND:

We hereby report on our experience from Naples (South Italy), where the peak of coronavirus disease 2019 (COVID-19) has already passed.

METHODS:

Assuming that COVID-19 will be circulating until vaccination and/or herd immunity is achieved (possibly not earlier than 2021), we have developed a protocol for the long-term management of multiple sclerosis (MS).

RESULTS:

We have defined a pathway for the access to the MS Centre with logistic, preventative and clinical recommendations, and have also included 14-day self-isolation and COVID-19 testing before some disease modifying treatments.

DISCUSSION:

Overall, we believe our experience could be helpful for MS management in the upcoming months.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Diagnostic study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Mult Scler Relat Disord Year: 2020 Document Type: Article Affiliation country: J.msard.2020.102282

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Diagnostic study / Prognostic study Topics: Long Covid / Vaccines Limits: Humans Country/Region as subject: Europa Language: English Journal: Mult Scler Relat Disord Year: 2020 Document Type: Article Affiliation country: J.msard.2020.102282